Almela P, Cuenca-Bermejo L, Yuste, JE, Estrada C, de Pablos V, Bautista-Hernández V, Fernández-Villalba E, Laorden ML, Herrero MT. Cardiac noradrenaline turnover and heat shock protein 27 phosphorylation in dyskinetic monkeys. Mov Disord. 2019; 4:698-703 https://doi:10.1002/mds.27958.
Barcia C, De Pablos V, Bautista-Hernández V, Sanchez-Bahillo A, Fernández-Barreiro A, Poza M, Herrero MT. Measurement of motor disability in MPTP-treated macaques using a telemetry system for estimating circadian motor activity. J Neurosci Methods. 2004; 134: 59-64. https://doi: 10.1016/jneumeth.2003.10.017.
Blauwendraat C, Heilbron K, Vallerga CL, Bandres‐Ciga S, von Coelln R, Pihlstrøm, L, Singleton AB. Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms. Movement Disorders. 2019; 34: 866–875. 10.1002/mds.27659
Bouhaddi M, Vuillier F, Fortrat JO, Cappelle S, Henriet MT, Rumbach L, Regnard J. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson’s disease: involvement of L-dopa therapy. Auton Neurosci. 2004; 116: 30–38. https://doi.org/10.1016/j.autneu.2004.06.009.
Carmona‑Abellan M, Martínez‑Valbuena I, DiCaudo C, Marcilla I, Luquin MR. Cardiac sympathetic innervation in the MPTP non‑human primate model of Parkinson disease. Clinical Autonomic Research. 2019; 29: 415–425. https://doi: 10.1007/s10286-019-00620-0.
Cuenca L, Gil-Martinez AL, Cano-Fernández L, Sánchez-Rodrigo C, Estrada C, Fernández-Villalba E, Herrero MT. Parkinson's disease: a short story of 200 years. Histol Histopathol. 2019; 34:573-591. https://doi: 10.14670/HH-18-073.
Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE. Evidence that incidental Lewy body disease is presymptomatic Parkinson’s disease. Acta Neuropathol. 2008; 115:437-444. https://doi: 10.1007/s00401-008-0345-7.
Dunkley P, Bobrowskaya L, Graham ME, von Nagy-Felsobuki EI, Dickson PW. Tyrosine hydroxylase phosphorylation: regulation and consequences. J Neurochem. 2004; 91:1025-1043. https://doi.org/10.1111/j.1471-4159.2004.02797.x.
Fabbri M, Ferreira JJ, Lees A, Stocchi F, Poewe W, Tolosa E, Rascol O. Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine. Mov Disord. 2018; 33:1528-1539. https://doi: 10.1002/mds.27475.
Friehs I, Cowan DB, Choi YH, Black KM, Barnett R, Bhasin MK, Daly C, Dillon SJ, Libermann, TA, McGowan FX, del Nido PJ, Levitsky S, McCully JD. Pressure-overload hypertrophy of the developing heart reveals activation of divergent gene and protein pathways in the left and right ventricular myocardium. Am J Physiol Heart Circ Physiol. 2013; 304:697-708. https://doi: 10.1152/ajpheart.00802.2012.
Fukumitsu N, Suzuki M, Fukuda T, Kiyono Y, Kajiyama S, Saji H. Reduced 125I-meta-iodobenzylguanidine uptake and norepinephrine transporter density in the hearts of mice with MPTP-induced Parkinsonism. Nucl Med Biol. 2006; 33:37-42. https://doi.org/10.1016/j.nucmedbio.2005.07.010.
Fujishiro H, Frigerio R, Burnett M, Klos KJ, Josephs KA, DelleDonne A, Parisi JE, Ahlskog JE, Dickson DW. Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson’s disease. Mov Disord. 2008; 23: 1085-1092. https://doi: 10.1002/mds.21989.
Godang K, Saul JP, Wyller VBB. Autonomic cardiovascular control changes in recent heart transplant recipients lead to physiological limitations in response to orthostatic challenge and isometric exercise. Eur J Appl Physiol. 2019; 119:2225‐2236. https://doi.org/10.1007/s00421-019-04207-5.
Goldstein DS, Pekker MJ, Eisenhofer G, Sharabi Y. Computational modelling reveals multiple abnormalities of myocardial noaredenrgic function in Lewy body disease. JCI Insight. 2019; 4: e130441. https://doi.org/10.1172/jci.insight.130441.
Haapaniemi TH, Kallio MA, Korpelainen JT, Suominen K, Tolonen U, Sotaniemi KA, Myllylä VV. Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson’s disease. J Neurol. 2000; 247: 868-874. https://doi.org/10.1007/s004150070075.
Herrero MT, Augood SJ, Asensi H, Hirsch EC, Agid Y, Obeso JA, Emson PC. Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys. Mol Brain Res. 1996a; 42:149-155. https://doi: 10.1016/s0169-328x (96)00157-x.
Herrero MT, Levy R, Ruberg M, Luquin MR, Villares J, Guillen J, Faucheux B, Javoy-Agid F, Guridi J, Agid Y, Obeso JA, Hirsch EC. Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum. Neurology. 1996b;47:219-224. https://doi.org/10.1212/wnl.47.1.219.
Jain S, Goldstein DS. Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiol Dis. 2012; 46:572-580. https://doi.org/10.1016/j.nbd.2011.10.025.
Kastner A, Herrero MT, Hirsch EC, Guillen J, Luquin MR, Javoy-Agid F., Obeso JA, Agid Y. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP–intoxicated monkeys: Effect of levodopa and GM1 ganglioside therapy. Ann Neurol. 1994; 36: 206-214. https://doi: 10.1002/ana.410360213.
Knudsen K, Borghammer P. Imaging the Autonomic Nervous System in Parkinson's Disease. Curr Neurol Neurosci Rep. 2018; 18:79-92. doi: 10.1007/s11910-018-0889-4.
Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983; 219:979-980. https://doi.org/10.1126/science.6823561.
Langston JW, Langston EB, Irwin I. MPTP-induced parkinsonism in human and non-human primates: clinical and experimental aspects. Acta Neurol Scand Suppl. 1984; 100:49-54.
Liu X, Wei B, Bi Q, Sun O, Li L, He J, Weng Y, Zhang S, Mao G, Bao Y, Wan S, Shen XZ, Yan J, Shi P. MPTP-Induced Impairment of Cardiovascular Function. Neurotox Res. 2020; 38:27-37. doi: 10.1007/s12640-020-00182-4.
Luthman J, Sundström E. No apparent difference in the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on the sympathetic system in NMRI and C57 BL/6 mice. Toxicol. Lett. 1990; 54:83-92. https://doi.org/10.1016/0378-4274(90)90059-u.
Magarkar A, Parkkila P, Viitala T, Lajunen T, Mobarak E, Licari G, Cramariuc O, Vauthey E, Róg T, Bunker A. Membrane bound COMT isoform is an interfacial enzyme: general mechanism and new drug design paradigm. Chem Commun. 2018; 54:3440-3443. https://doi: 10.1039/c8cc00221e.
Mitsui J, Saito Y, Momose T, Shimizua J, Araia N, Shibaharad J, Ugawa Y, Kanazawa I, Tsuji S, Murayama S. Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease. J Neurol Sci. 2006; 243:101-104. https://doi.org/10.1016/j.jns.2005.11.034.
Nakashima A, Ota A, Kaneko YS, Mori K, Nagasaki H, Nagatsu T. A possible pathophysiological role of tyrosine hydroxylase in Parkinson's disease suggested by postmortem brain biochemistry: a contribution for the special 70th birthday symposium in honor of Prof. Peter Riederer. J Neural Transm. 2013; 120:49-54. https://doi.org/10.1007/s00702-012-0828-5.
Noack, C., Schroeder, C., Heusser, K., Lipp, A., 2014. Cardiovascular effects of levodopa in Parkinson’s disease. Parkinsonism Relat Disord 20:815–818. https://doi.org/10.1016/j.parkreldis.2014.04.007
Nygaard S, Christensen, A.H., Rolid, K., Nytrøen, K., Gullestad, L., Fiane, A., Thaulow, E., Døhlen, G., Post, K, Singer C, Papapetropoulos S. Cardiac denervation and dysautonomia in Parkinson's disease: a review of screening techniques. Parkinsonism Relat Disord. 2008; 14:524-531. https://doi.org/10.1016/j.parkreldis.2008.03.008.
Orimo S, Oka T, Miura H, Tsuchiya K, Mori F, Wakabayashi K, Nagao T, Yokochi M. Sympathetic cardiac denervation in Parkinson’s disease and pure autonomic failure but not in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002; 73:776-777. https://doi.org/10.1136/jnnp.73.6.776.
Orimo S, Uchihara T, Nakamura A, Mori F, Ikeuchi T, Onodera O, Nishizawa M, Ishikawa A, Kakita, A, Wakabayashi K, Takahashi H. Cardiac sympathetic denervation in Parkinson’s disease linked to SNCA duplication. Acta Neuropathol. 2008; 116:575-577. https://doi.org/10.1007/s00401-008-0428-5.
Pérez-Otaño I, Herrero MT, Luquin MR, Obeso JA, Del Río J. Chronic MPTP treatment reduces substance P and met-enkephalin content in the basal ganglia of the marmoset. Brain Res. 1992; 585:156-60. https://doi: 0.1016/0006-8993(92)91201-o.
Plotegher N, Berti G, Ferrari E, Tessari I, Zanetti M, Lunelli L, Greggio EM, Veronesi M, Girotto S, Dalla Serra M, Perego C, Casella L, Bubacco L. DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function. Sci Rep. 2017 7:40699 https://doi.org/10.1038/srep40699.
Reichmann H, Lees A, Rocha JF, Magalhães D, Soares-da-Silva P, OPTIPARK investigators. Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study. Transl Neurodegener, 2020; 9:14. https://doi: 10.1186/s40035-020-00187-1.
Rivinius R, Helmschrott Ruhparwar MA Rahm AK, Darche FF, Thomas D, Bruckner T, Ehlermann, P, Katus HA, Doesch AO. Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart. Clin Res Cardiol. 2018; 107:138‐147. Https://doi.org/10.1007/s00392-017-1165-1173.
Schapira AH, Olanow C W, Greenamyre J T , Bezard E. Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: Future therapeutic perspectives. Lancet. 2014; 384: 545–555. 10.1016/S0140-6736(14)61010-2
Sanyal SN, Wada T, Yamabe M, Anai H, Miyamoto S, Shimada T, Ono K. Cardiac Autonomic Nerve Abnormalities in Chronic Heart Failure Are Associated With Presynaptic Vagal Nerve Degeneration. Pathophysiology. 2012; 19:253-60. doi: 10.1016/j.pathophys.2012.07.004.
Weihe E, Schutz B, Hartschuh W, Anlauf M, Schafer MK, Eiden LE. Coexpression of cholinergic and noradrenergic phenotypes in human and nonhuman autonomic nervous system. J Comp Neurol. 2005; 492:370–379. https://doi.org/10.1002/cne.20745.
West MJ. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci. 1999; 22:51-61. https://doi.org/10.1016/s0166-2236(98)01362-9.
Zeng BY, Balfour RH, Jackson MJ, Rose S, Jenner P. Expression of catechol-O-methyltransferase in the brain and periphery of normal and MPTP-treated common marmosets. J Neural Transm. 2010; 117:45-51.https://doi: 10.1007/s00702-009-0315-9.